The tariff war starts in February with initial estimates ranging from 10%-25%. Companies in the defense and aerospace sectors and Raw Materials and Commodities Producers could benefit. The logistics and shipping industries could be impacted, but companies that offer domestic transportation solutions might benefit from increased demand for goods. It’s no secret President Trump....

The tariff war starts in February with initial estimates ranging from 10%-25%. Companies in the defense and aerospace sectors and Raw Materials and Commodities Producers could benefit. The logistics and shipping industries could be impacted, but companies that offer domestic transportation solutions might benefit from increased demand for goods. It’s no secret President Trump....

The tariff war starts in February with initial estimates ranging from 10%-25%. Companies in the defense and aerospace sectors and Raw Materials and Commodities Producers could benefit. The logistics and shipping industries could be impacted, but companies that offer domestic transportation solutions might benefit from increased demand for goods. It’s no secret President Trump....

For investors that missed Nvidia’s (NVDA) incredible triple-digit return of 145% in 2024 and the stock’s five-year return of over 2,000%, many feel as though they may have missed the artificial intelligence (AI) boom. The good news is that the AI revolution spans several sectors, from cloud computing and semiconductor manufacturing to software development....

by Market Updates and Alerts 390,000 JOBS WERE CREATED IN THE US ECONOMY, UP FROM THE PROJECTED 328,000; The US stock market has already gone from plus to minus this morning. One of the main reasons for the market slump is news that Tesla CEO Elon Musk said the leading electric car company needs....

by Market Updates and Alerts BRISTOL MYERS SQUIBB TO ACQUIRE TURNING POINT AT $76 SHARE Turning Point Therapeutics (NASDAQ: YPTX) was up 118.35% after announcing a merger agreement with Bristol Myers Squibb (NYSE: BMY). Bristol Myers Squibb will purchase Turning Point Therapeutics at $76 per share, according to the agreement terms. The Board of directors....

FUTURES CONTRACTS TRY TO KEEP UP IN THE US, BUT STOCKS TUMBLE IN EUROPE IN THE FACE OF STRONG INFLATION AND IMPACT ON THE INDUSTRY Markets struggle to find direction. On the one hand, stocks at attractive prices encourage investors to buy. On the other hand, the signs that inflation remains firm and strong,....

EU CHOOSES SIGA’S TECOVIRIMA TO FIGHT MONKEYPOX SIGA Technologies Inc. (NASDAQ: SIGA) jumped 41.91% after the biotech announced on May 19, 2022, the approval its IV formulation of the TPOXX therapy for smallpox treatment. Another potential driver for the stock surge is the Monkeypox virus outbreak which is endemic to Africa and rare in other....

by Market Updates and Alerts SIGA RECEIVES FDA APPROVAL FOR IV TPOXX IN THE US Siga Technologies Inc. (NASDAQ: SIGA) was up 43.35% after announcing the FDA had approved its intravenous (IV) TPOXX formula for smallpox treatment. The formulation is a vital alternative for those that cannot ingest then oral TPOXX capsules. Oral TPOXX is....

Major US futures started the day up more than 1%, while the European Stoxx 600 was up 1.5%; oil on the rise with prospects for increased demand US AND EUROPEAN MARKETS UP ON BACK OF ‘ECONOMY-BOOSTING’ INTEREST RATES IN CHINA Investors return to equities and lift both European markets and US index futures contracts.....